| 2124 |
increased, Bax expression
Short Name
increased, Bax
|
1 |
Molecular |
Apr 4, 2023 |
May 20, 2025 |
2 AOPs
|
| 2125 |
Increased fat mass
Short Name
Increased fat mass
|
0 |
Organ |
Apr 5, 2023 |
Apr 5, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2126 |
Estrogen receptor alpha inactivation
Short Name
ERa inactivation
|
0 |
Molecular |
Apr 5, 2023 |
Apr 10, 2023 |
2 AOPs
|
| 2127 |
Increased adipocyte size
Short Name
Increased adipocyte size
|
0 |
Cellular |
Apr 5, 2023 |
Apr 5, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2128 |
Increased adipocyte numbers
Short Name
Increased adipocyte numbers
|
0 |
Cellular |
Apr 5, 2023 |
Apr 5, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2129 |
Metabolically unhealthy Obesity
Short Name
Metabolically unhealthy Obesity
|
0 |
Individual |
Apr 5, 2023 |
Apr 5, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2130 |
increased lipid accumulation
Short Name
increased lipid accumulation
|
0 |
Cellular |
Apr 5, 2023 |
Apr 5, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2131 |
Conjugation, GSH
Short Name
Conjugation, GSH
|
1 |
Cellular |
Apr 5, 2023 |
Sep 14, 2023 |
492: Glutathione conjugation leading to reproductive dysfunction via oxidative stress
|
| 2132 |
Increased pro-inflammatory cytokine expression
Short Name
Increased cytokine expression
|
0 |
Cellular |
Apr 6, 2023 |
Apr 6, 2023 |
493: ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity
|
| 2133 |
Increase, Glucuronidation of T4
Short Name
Increase, Glucuronidation of T4
|
0 |
Molecular |
Apr 12, 2023 |
Apr 12, 2023 |
None
|
| 2134 |
Increase, Androgen receptor protein expression/abundance
Short Name
Increase, AR protein expression/abundance
|
0 |
Cellular |
May 11, 2023 |
Dec 31, 2024 |
495: Androgen receptor activation leading to prostate cancer
|
| 2135 |
Prostate cancer
Short Name
Prostate cancer
|
0 |
Individual |
May 11, 2023 |
May 11, 2023 |
495: Androgen receptor activation leading to prostate cancer
|
| 2136 |
prostatic intraepithelial neoplasia
Short Name
prostatic intraepithelial neoplasia
|
0 |
Tissue |
May 11, 2023 |
May 11, 2023 |
495: Androgen receptor activation leading to prostate cancer
|
| 2137 |
Increase, Gonadotropins concentration in plasma
Short Name
Increase, Gonadotropins concentration in plasma
|
1 |
Cellular |
May 16, 2023 |
Jan 29, 2026 |
2 AOPs
|
| 2139 |
Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma
Short Name
Reduction, the ratio of E2/11-KT in plasma
|
0 |
Organ |
May 16, 2023 |
May 16, 2023 |
496: Androgen receptor agonism leading to reproduction dysfunction (in zebrafish)
|
| 2140 |
Decreased spawning and cumulative fecundity, decreased gonadosomatic index
Short Name
Decreased spawning and cumulative fecundity, decreased GSI
|
0 |
Individual |
May 16, 2023 |
May 16, 2023 |
None
|
| 2141 |
Disruption, Estrogen receptor
Short Name
Disruption of ER
|
0 |
Molecular |
May 17, 2023 |
May 17, 2023 |
476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
|
| 2142 |
Depletion, Ectoplasmic specialization (ES)
Short Name
Depletion of ES
|
0 |
Cellular |
May 17, 2023 |
May 17, 2023 |
476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
|
| 2144 |
Impaired insulin signaling
Short Name
Impaired insulin signaling
|
0 |
Cellular |
May 25, 2023 |
May 25, 2023 |
497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
|
| 2145 |
Metabolic syndrome
Short Name
Metabolic syndrome
|
0 |
Population |
May 25, 2023 |
May 25, 2023 |
497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
|
| 2146 |
Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
Short Name
Activation of MEK, ERK1/2
|
1 |
Molecular |
May 25, 2023 |
Jul 28, 2023 |
2 AOPs
|
| 2147 |
Decreased, Viable Offspring
Short Name
Decreased, Viable Offspring
|
2 |
Individual |
Jun 2, 2023 |
Apr 10, 2024 |
2 AOPs
|
| 2148 |
Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
Short Name
Increased LCN2/iron complex
|
0 |
Molecular |
Jun 15, 2023 |
Jun 15, 2023 |
498: Increased LCN2/iron complex leading to neurological disorders
|
| 2149 |
Increased intracelluar Iron accumulation
Short Name
Increased intracelluar Iron
|
0 |
Cellular |
Jun 15, 2023 |
Jun 15, 2023 |
2 AOPs
|
| 2150 |
Neurological disorder
Short Name
Neurological disorder
|
0 |
Individual |
Jun 15, 2023 |
Jun 15, 2023 |
3 AOPs
|